Optimal periodic control of a drug delivery system

Computers and Chemical Engineering

Volumn 32, Issue 10, 2008, Pages 2256-2262

  Varigonda, Subbarao ^a   Georgiou, Tryphon T ^b   Siegel, Ronald A ^c   Daoutidis, Prodromos ^b  

^a UNITED TECHNOLOGIES RESEARCH CENTER   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Differential flatness; Drug delivery; Optimal periodic control

Indexed keywords

AUTOMATION; CHEMOTHERAPY; CONTROL THEORY; DRUG DOSAGE; MILITARY DATA PROCESSING; OPTIMAL CONTROL SYSTEMS; PHOTOACOUSTIC EFFECT; STANDARDS;

(E ,2E) THEORY; DIFFERENTIAL FLATNESS; DRUG DELIVERY SYSTEM (DDS); DRUG TOLERANCE; DYNAMIC OPTIMIZATION PROBLEM (DOP); ELSEVIER (CO); OPTIMAL PERIODIC CONTROL; PARAMETER SPACES; PARAMETER VALUES; PERIODIC DELIVERY; SHOOTING METHODS; TIME-AVERAGED;

DRUG DELIVERY;

EID: 47849119782     PISSN: 00981354     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.compchemeng.2007.11.003     Document Type: Article

References (28)

1. Bauer J.A., Balthasar J.P., and Fung H.-L. Application of pharmacodynamic modeling for designing time-variant dosing regiments to overcome nitroglycerin tolerance in experimental heart failure. Pharmaceut. Res. 14 (1997) 1140-1145
2. Bernstein D.S., and Gilbert E.G. Optimal periodic control: The π-test revisited. IEEE Trans. Automat. Contr. AC-25 4 (1980) 673-684
3. Bittanti S., Fronza G., and Guardabassi G. Periodic control: A frequency domain approach. IEEE Trans. Automat. Contr. AC-18 1 (1973) 33-38
4. Bittanti S., and Guardabassi G. Optimal periodic control and periodic systems analysis: An overview. Proceedings of the IEEE CDC (1986)
5. Bryson A.E. Dynamic optimization (1999), Addison-Wesley
6. Dibrov B.F., Zhabotinsky A.M., Neyfakh Y.A., Orlova M.P., and Churikova L.I. Mathematical model of cancer chemotherapy. Periodic schedules of phasespecific cytotoxic-agent administration increasing the selectivity of therapy. Math. Biosc. 73 (1985) 1-31
7. Fliess M. Flatness and defect of nonlinear systems: Introductory theory and examples. Int. J. Control 61 6 (1995) 1327-1361
8. Gobburu J.V.S., and Jusko W.J. Role of dosage regimen in controlling indirect pharmacodynamic responses. Adv. Drug Deliv. Revs. 33 (1998) 221-233
9. Kansal, S., Forbes, J. F., Guay, M. (2000). Constrained optimization of nonlinear, dynamic chemical processes a normalized form approach. In Preprints of IFAC ADCHEM (Vol. 2). Pisa, Italy.
10. Li, Y. -X., Goldbeter, A. (1989). Frequency specicity in intercellular communication, Biophys. J. 55, (1), 125-145. http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1330448.
11. Ekblad E.B., and Licko V. A model eliciting transient responses. Amer. J. Physiol. 246 (1984) R114-R121
12. Mahadevan, R., Agrawal, S. K., Doyle III, F. J. (2000). A flatness based approach to optimization in fed-batch bioreactors. In Preprints of IFAC ADCHEM (Vol. 1). Pisa, Italy.
13. Martin, P., Murray, R. M., Rouchon, P. (2003). Flat systems, equivalence and trajectory generation. Technical report, CDS Technical report.http://www.cds.caltech.edu/∼murray/papers/2003d_mmr03-cds.html.
14. Maurer H., Büskens C., and Feichtinger G. Solution techniques for periodic control problems: A case study in production planning. Optimal Control Appl. and Methods 19 3 (1998) 185-203
15. Modi N.B., Lindemulder B., and Gupta S.K. Single- and multiple-dose pharmacokinetics of an oral once-a-day osmotic controlled-release OROSR (methylphenidate HCl) formulation. J. Clin. Pharmacol. 40 (2000) 379-388
16. Oldenburg, J. & Marquardt, W. (2000). Dynamic optimization based on higher order dierential model representations. In Preprints of IFAC ADCHEM (Vol. 2). Pisa, Italy.
17. Park K., Verotta D., Gupta S.K., and Sheiner L.B. Use of a pharmacokinetic/pharmacodynamic model to design an optimal dose input prole. J. Pharmacokinet. Biopharm. 26 (1998) 471-492
18. Parker J.O., Amies M.H., Hawkinson R.W., Heilman J.M., Hougham A.J., Vollmer M.C., and Wilson R.R. Intermittent transdermal nitroglycerin therapy in angina pectoris. clinically effctive without tolerance or rebound. Circulation 91 (1995) 1368-1374
19. Parker R.S., and Doyle F.J.I. Control-relevant modeling in drug delivery. Adv. Drug Deliv. Revs. 48 (2001) 211-228
20. Peper A., Grimbergen C.A., Kraal J.W., and Englebart J.H. An approach to the modeling of the tolerance mechanism in the drug effect. I: The drug effect as adisturbance of regulations. J. Theor. Biol. 127 (1987) 413-426
21. Porchet H.C., Benowitz N.L., and Sheiner L. Pharmacodynamic model of tolerance: Application to nicotine. J. Pharmacol. Exp. Therap. 244 (1988) 231-236
22. Process Systems Enterprise (PSE) (2007). gPROMS: General process modeling system. http://www.psenterprise.com
23. Raffa R.B., and Tallarida R. The concept of a changing receptor concentration: Implications for the theory of drug action. J. Theor. Biol 115 (1985) 625-632
24. Santoro N., Filicori M., and Crowley W.F.J. Hypogonadotropic disorders in men and women: Diagnosis and therapy with pulsatile gonadotropinreleasing hormone. Endocr. Revs. 7 (1985) 11-23
25. Sundareshan M.K., and Acharya R.S. Optimal control in cancer therapy by simultaneous consideration of normal and cancer cell proliferation kinetics. Int. J. Systems Sci. 15 (1984) 773-776
26. van Nieuwstadt M., Rathinam M., and Murray R.M. Differential flatness and absolute equivalence of nonlinear control systems. SIAM J. Control Optim. 36 4 (1998) 1225-1239
27. Varigonda S., Georgiou T.T., and Daoutidis P. Numerical solution of the optimal periodic control problem using differential flatness. IEEE Trans. Automat. Contr. 49 2 (2004) 271-275
28. Wang E.O., Balthasar J.P., and Fung H.-L. Pharmacodynamics of in vivo nitroglycerin tolerance in normal conscious rats: Effects of dose and dosing protocol. Pharmaceut. Res. 21 (2004) 114-120